This Lancet trial followed 3,283 hospital patients with nearly 6,000 peripheral IV catheters, the same kind of small line used for most infusions, to test whether lines need routine replacement or can stay until there is a clinical reason to change them.
The most common complication, phlebitis (irritation or inflammation of the vein), occurred in about 7% of patients in both groups, and no serious adverse events related to the trial interventions were recorded.
The result changed hospital practice worldwide, showing catheters can safely remain in place longer when monitored by nursing staff.
For consumers, the relevant point is the safety profile: peripheral IVs placed and monitored by trained nurses are a routine, well-studied procedure whose typical risks are minor and local, like bruising or vein irritation. Note this studied multi-day hospital lines; a short infusion visit is a lower-exposure scenario.
Conducted in hospital inpatients with catheters in place for days, a higher-exposure setting than a single infusion visit, so rates are not directly transferable.
These are factual summaries of published research, provided for general information. They are not medical advice, and IV Drip Dash is not a medical provider. Licensed providers make all clinical decisions.
Request a drip